相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predictive Capacity of Population Pharmacokinetic Models for the Tacrolimus Dose Requirements of Pediatric Solid Organ Transplant Recipients
Amy L. Pasternak et al.
THERAPEUTIC DRUG MONITORING (2023)
PharmVar GeneFocus: CYP3A5
Cristina Rodriguez-Antona et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2022)
CYP3A4/5 genotypes and age codetermine tacrolimus concentration and dosage in pediatric heart transplant recipients
Li Liu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2022)
CYP3A-status is associated with blood concentration and dose-requirement of tacrolimus in heart transplant recipients
Mate Deri et al.
SCIENTIFIC REPORTS (2021)
Age-Related Changes in Pediatric Physiology: Quantitative Analysis of Organ Weights and Blood Flows Age-Related Changes in Pediatric Physiology
Hsuan Ping Chang et al.
AAPS JOURNAL (2021)
Are body surface area based estimates of liver volume applicable to children with overweight or obesity? An in vivo validation study
Chelsea Hosey-Cojocari et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients
Abbie D. Leino et al.
PHARMACOTHERAPY (2021)
Systematic external evaluation of published population pharmacokinetic models for tacrolimus in adult liver transplant recipients
Xiaojun Cai et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Evaluating tacrolimus pharmacokinetic models in adult renal transplant recipients with different CYP3A5 genotypes
Can Hu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Predicting tacrolimus concentrations in children receiving a heart transplant using a population pharmacokinetic model
Joseph E. Rower et al.
BMJ PAEDIATRICS OPEN (2017)
External evaluation of published population pharmacokinetic models of tacrolimus in adult renal transplant recipients
Chen-Yan Zhao et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Population Pharmacokinetic Modelling and Bayesian Estimation of Tacrolimus Exposure: Is this Clinically Useful for Dosage Prediction Yet?
Emily Brooks et al.
CLINICAL PHARMACOKINETICS (2016)
CYP3A pharmacogenetics and tacrolimus disposition in adult heart transplant recipients
Kimberly M. Deininger et al.
CLINICAL TRANSPLANTATION (2016)
The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Lung and Heart-Lung Transplant Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant
Roger D. Yusen et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2016)
The Registry of the International Society for Heart and Lung Transplantation: Nineteenth Pediatric Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant
Joseph W. Rossano et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2016)
Changes in Risk Profile Over Time in the Population of a Pediatric Heart Transplant Program
Olaf Reinhartz et al.
ANNALS OF THORACIC SURGERY (2015)
Population pharmacokinetic analysis of tacrolimus in Mexican paediatric renal transplant patients: role of CYP3A5 genotype and formulation
Carlos Orlando Jacobo-Cabral et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients
Mariam H. Abdel Jalil et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients
Nastya Kassir et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach
Vanessa Guy-Viterbo et al.
PHARMACOGENOMICS (2014)
Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients
Wei Zhao et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Population pharmacokinetic analysis of tacrolimus in the first year after pediatric liver transplantation
V. Guy-Viterbo et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
PharmGKB summary: very important pharmacogene information for CYP3A5
Jatinder Lamba et al.
PHARMACOGENETICS AND GENOMICS (2012)
Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients
Violette Gijsen et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2011)
Population Pharmacokinetics of Tacrolimus in Pediatric Liver Transplantation: Early Posttransplantation Clearance
Johan E. Wallin et al.
THERAPEUTIC DRUG MONITORING (2011)
Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients
W. Zhao et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Trough Tacrolimus Concentrations in the First Week After Kidney Transplantation Are Related to Acute Rejection
Alberto M. Borobia et al.
THERAPEUTIC DRUG MONITORING (2009)
Heights and haematology: the story of haemoglobin at altitude
Jeremy S. Windsor et al.
POSTGRADUATE MEDICAL JOURNAL (2007)
Models for time-varying covariates in population pharmacokinetic-pharmacodynamic analysis
U Wählby et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Bayesian forecasting and prediction of tacrolimus concentrations in pediatric liver and adult renal transplant recipients
C Willis et al.
THERAPEUTIC DRUG MONITORING (2003)
Comparison of an ELISA and an LC/MS/MS method for measuring tacrolimus concentrations and making dosage decisions in transplant recipients
CE Staatz et al.
THERAPEUTIC DRUG MONITORING (2002)
Mechanisms of clinically relevant drug interactions associated with tacrolimus
U Christians et al.
CLINICAL PHARMACOKINETICS (2002)
Low tacrolimus concentrations and increased risk of early acute rejection in adult renal transplantation
C Staatz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2001)
分享论文
